FDA’s McClellan Touts Scientific Analysis As Part Of Ephedra Ban
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Mark McClellan, MD/PhD, said the "framework" for the outright ban of ephedra will be based on substantive scientific evidence as the agency prepares to publish the reg
You may also be interested in...
NTP Board Shows Support For More Dietary Supplement Evaluations
Increasing the number of dietary supplements to be evaluated by the National Toxicology Program would be warranted, according to the organization's Board of Scientific Counselors
CFSAN Examines AER Reporting Following Bitter Orange Miscalculation
FDA's Center for Food Safety & Applied Nutrition is in the process of making corrections to its adverse event reporting procedures for bitter orange following a miscalculation of the number of AERs tied to the ingredient
A Bitter Pill? Researchers Challenge Citrus Aurantium Safety, Efficacy
The inclusion of Citrus aurantium in weight-loss products is not supported by substantial clinical evidence, researchers conclude in the September issue of Experimental Biology & Medicine